Methylphenidate Improves Autonomic Functioning among Youth with Attention-Deficit/Hyperactivity Disorder
Stephanie S J Morris1, Erica D Musser2, Rachel B Tenenbaum3
1Center for Children and Families, Department of Psychology, Florida International University, Miami, FL, USA. smorr064@fiu.ed.
Research on Child and Adolescent Psychopathology
|October 6, 2021
Summary
Methylphenidate (MPH) medication for attention-deficit/hyperactivity disorder (ADHD) in youth normalizes autonomic nervous system (ANS) functioning. This study found OROS MPH normalized respiratory sinus arrhythmia (RSA) and electrodermal activity (EDA) in ADHD youth to typical levels.
Area of Science:
- Neuroscience
- Pediatrics
- Psychopharmacology
Background:
- Youth with ADHD often exhibit atypical autonomic nervous system (ANS) functioning, with reduced sympathetic and parasympathetic activity.
- Psychostimulants like methylphenidate (MPH) are common ADHD treatments, but their impact on ANS indexes in youth is understudied.
Purpose of the Study:
- To investigate the effects of Osmotic Release Oral System (OROS) MPH on parasympathetic (respiratory sinus arrhythmia [RSA]) and sympathetic (electrodermal activity [EDA]) functioning in youth with ADHD.
- To compare ANS functioning in youth with ADHD on medication versus placebo against typically developing youth.
Main Methods:
- A within-subjects, double-masked, cross-over design was employed.
- 256 participants (157 with ADHD), aged 5-13, completed a 2-minute resting baseline task measuring RSA and EDA.
- ADHD youth underwent assessment twice (3 weeks apart) under active OROS MPH and placebo conditions, counterbalanced.
Main Results:
- Youth with ADHD on placebo showed reduced RSA and EDA compared to typically developing youth.
- Youth with ADHD on OROS MPH did not significantly differ from typically developing youth in RSA or EDA.
- OROS MPH normalized both RSA and EDA levels in youth with ADHD.
Conclusions:
- OROS MPH effectively normalizes autonomic nervous system functioning (RSA and EDA) in youth with ADHD, bringing them to levels comparable to typically developing peers.
- These findings highlight the importance of considering MPH's impact on ANS when studying youth with ADHD.
- Future research should incorporate ANS measures to better understand ADHD and its treatment.
Keywords:
Attention-deficit/hyperactivity disorderElectrodermal activityMethylphenidateRespiratory sinus arrhythmiaMore Related Videos
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
5.9K
13:09Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
10.5K
Related Concept Videos
01:30Attention-Deficit/Hyperactivity Disorder
429
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
429
01:28Adrenergic Agonists: Mixed-Action Agents
1.1K
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
1.1K
01:30Adrenergic Agonists: Therapeutic Uses
1.2K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
1.2K
01:26Modeling in Therapy
173
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
173
01:23Drugs Acting on Autonomic Ganglia: Stimulants
1.7K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.7K
01:25Adrenergic Agonists: Indirect-Acting Agents
2.1K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.1K